5:27 PM · 2 April 2025

BREAKING: Novavax shares tumble as FDA misses deadline For Covid-19 vaccine approval

The FDA has missed the deadline for making a key decision regarding a Novavax (NVAX.US) Covid-19 vaccine, days after the Food and Drug Administration’s vaccine chief was pushed out. Novavax’s application needed more data and was unlikely to be approved soon - was said by people familiar with a matter, citted by WSJ.

This information is seriously damaging the sentiment around the company and is undermining its current ability to maintain its business system. The shares are losing over 1.5%, although at one point the declines were as high as 4%.

 

Source: xStation 

5 August 2026, 1:09 PM

Arista Networks Beats Expectations and Provides Fresh Support for the AI Investment Cycle

5 August 2026, 6:51 AM

Market wrap (05.08.2026)

4 August 2026, 9:54 PM

AMD Did Everything Right… But Only Right

4 August 2026, 9:33 PM

SpaceX Shares Drop 6% After Earnings 🚩 Is Space No Longer Enough for Wall Street?

The financial instruments we offer, especially CFDs, can be highly risky. Fractional Shares (FS) is an acquired from XTB fiduciary right to fractional parts of stocks and ETFs. FS are not a separate financial instrument. The limited corporate rights are associated with FS.
This page was not created for investors residing in Brazil. This brokerage is not authorized by the Comissão de Valores Mobiliários (CVM) or the Brazilian Central Bank (BCB). The content of this page should not be characterized as an investment offer in Brazil or for investors residing in that country.
Losses can exceed deposits